NGM09 NGM-120-CX-202 A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants with Colorectal Cancer who have Cancer Cachexia
Clinical Trial Grant
Administered By
Radiology, Abdominal Imaging
Awarded By
NGM Biopharmaceuticals, Inc.
Start Date
June 25, 2025
End Date
December 31, 2027
Administered By
Radiology, Abdominal Imaging
Awarded By
NGM Biopharmaceuticals, Inc.
Start Date
June 25, 2025
End Date
December 31, 2027